Inbiomotion
Developing biomarkers that PREdict bone metastasis
Inbiomotion has raised €2.1M across 1 funding round from 1 investor, most recently a Seed round in Jun 2012. Based in Barcelona, Spain; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.1M
€2,096,267
Funding rounds
1
Investors
1
distinct backers
Active since
2012-06
latest 2012-06
Funding by year
EUR raised per yearInbiomotion — funding by year — interactive chart.
Data table
| Inbiomotion — funding by year | |
|---|---|
| 2012 | €2.1M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-06-01 | Seed | €2.1M | Ysios Capital | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData